Laboratory Corporation of America Holdings (LH) continues to showcase strong performance in the bio-tech sector. Several renowned financial institutions have demonstrated confidence in LH by increasing their share holdings, including Franklin Resources Inc., Principal Financial Group Inc., Virtu Financial LLC, Toronto Dominion Bank, and Nomura Asset Management Co. Ltd. LH's stock has hit 52-week highs twice recently. Additionally, Q3 earnings exceeded expectations, leading the firm to raise its revenue guidance. Recent acquisitions include assets from Invitae and BioReference Health's diagnostics business, emphasizing LH’s strategic expansion. However, LabCorp's CEO is unlikely to see a pay rise this year. LabCorp has finalized acquisition of select assets of Invitae and plans to increase its mpox testing capacity. Despite lower-than-expected EPS for Q3 2024, bullish forecasts continue to come in. Select Laboratory Corporation assets have been sold to Tidal Investments LLC and Wellington Management Group LLP. Lastly, LabCorp has collaborated with Hawthorne Effect, unveiled new research on precision diagnostics, and completed the spin-off of Fortrea.
Laboratory Corporation of America Holdings LH News Analytics from Tue, 21 Jan 2014 08:00:00 GMT to Thu, 26 Dec 2024 09:18:33 GMT -
Rating 7
- Innovation 4
- Information 8
- Rumor -1
